当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析

益丰药房

(603939)

  

流通市值:268.30亿  总市值:268.30亿
流通股本:12.12亿   总股本:12.12亿

益丰药房(603939)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润5.46亿元,每股收益0.41元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1291956.18万元,未分配利润663782.25万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2683535.45万元,负债1391579.27万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入6,085,003,538.5924,433,165,197.517,285,899,932.6411,721,819,634.46
营业总成本5,386,162,931.8122,129,134,049.1615,631,502,380.8510,538,133,417.85
其他经营收益
营业利润727,664,900.372,453,723,769.81,786,801,453.441,272,348,418.64
利润总额723,639,787.142,456,394,852.411,769,955,687.281,263,589,794.94
净利润546,085,134.161,831,025,556.61,321,166,607.72945,793,936.37
每股收益
其他综合收益-75,076,268.9947,773,490.5132,352,825
综合收益总额546,085,134.161,906,101,825.591,368,940,098.23978,146,761.37
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计16,388,210,229.7516,825,997,154.2515,089,934,116.4514,699,680,085.95
非流动资产:
非流动资产合计10,447,144,268.2110,625,926,894.3310,981,452,997.0511,618,536,351.38
资产总计26,835,354,497.9627,451,924,048.5826,071,387,113.526,318,216,437.33
流动负债:
流动负债合计10,656,988,771.6211,752,772,950.1110,612,983,485.7210,639,572,046.16
非流动负债:
非流动负债合计3,258,803,928.913,320,542,814.713,575,961,193.193,793,477,289.75
负债合计13,915,792,700.5315,073,315,764.8214,188,944,678.9114,433,049,335.91
所有者权益(或股东权益):
归属于母公司股东权益合计12,133,848,482.511,634,287,444.8411,177,628,791.7611,153,968,695.51
股东权益合计12,919,561,797.4312,378,608,283.7611,882,442,434.5911,885,167,101.42
负债和股东权益合计26,835,354,497.9627,451,924,048.5826,071,387,113.526,318,216,437.33
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计7,013,341,234.5526,303,555,418.0519,349,072,108.8813,262,684,876.49
经营活动现金流出小计5,956,969,996.4422,945,107,403.6417,081,861,091.0711,693,019,088.3
经营活动产生的现金流量净额1,056,371,238.113,358,448,014.412,267,211,017.811,569,665,788.19
投资活动产生的现金流量:
投资活动现金流入小计5,121,166,287.9824,251,873,963.8922,618,211,396.515,337,215,954.79
投资活动现金流出小计5,427,070,017.7825,678,052,852.8122,981,387,474.3415,553,160,522.97
投资活动产生的现金流量净额-305,903,729.8-1,426,178,888.92-363,176,077.84-215,944,568.18
筹资活动产生的现金流量:
筹资活动现金流入小计-1,762,8001,753,0001,753,000
筹资活动现金流出小计328,357,053.982,481,561,351.782,077,528,121.251,297,144,025.24
筹资活动产生的现金流量净额-328,357,053.98-2,479,798,551.78-2,075,775,121.25-1,295,391,025.24
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额422,110,454.33-547,529,426.29-171,740,181.2858,330,194.77
期末现金及现金等价物余额2,035,378,898.561,613,268,444.231,989,057,689.242,219,128,065.29
补充资料:
现金及现金等价物的净增加额--547,529,426.29-58,330,194.77
最新报告期:2026-05-17
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
国泰海通周航,张澄,余文心1.581.812.062026-05-17
华创证券郑辰,高初蕾1.601.832.082026-05-15
中信建投袁全,刘若飞,沈兴熙,贺菊颖1.591.852.142026-05-13
华兴证券赵冰1.611.832.092026-05-12
国信证券彭思宇,陈曦炳1.611.862.102026-05-10
TOP↑